Gliosarcoma
Showing 26 - 50 of 458
Diffuse Intrinsic Pontine Glioma, Pediatric Brainstem Glioma, Pediatric Brainstem Gliosarcoma, Recurrent Trial in Boston
Active, not recruiting
- Diffuse Intrinsic Pontine Glioma
- +5 more
-
Boston, Massachusetts
- +1 more
May 3, 2022
Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling
Recruiting
- Recurrent Childhood Acute Myeloid Leukemia
- +17 more
-
Miami, FloridaNicklaus Children's Hospital
May 13, 2023
Recurrent Anaplastic Astrocytoma, Recurrent Anaplastic Oligoastrocytoma, Recurrent Anaplastic Oligodendroglioma Trial in Duarte
Active, not recruiting
- Recurrent Anaplastic Astrocytoma
- +6 more
- Carboxylesterase-expressing Allogeneic Neural Stem Cells
- +4 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jun 7, 2022
Glioblastoma, Adult Gliosarcoma, Tumors, Brain Trial in Seongnam (MSC11FCD)
Enrolling by invitation
- Glioblastoma
- +4 more
-
Seongnam, Kyunggido, Korea, Republic ofBundang CHA Medical Center
Jan 6, 2022
Glioblastoma, Gliosarcoma, Supratentorial Glioblastoma Trial in Rochester (radiation, other, biological, drug, procedure)
Recruiting
- Glioblastoma
- +2 more
- External Beam Radiation Therapy
- +5 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Apr 4, 2022
Giant Cell Glioblastoma, Glioblastoma, Gliosarcoma Trial in Rochester (other, biological, drug)
Active, not recruiting
- Giant Cell Glioblastoma
- +2 more
- Laboratory Biomarker Analysis
- +2 more
-
Rochester, MinnesotaMayo Clinic
Nov 3, 2021
CNS Tumors, Glioblastoma, Gliosarcoma, Adult Trial run by the (ONC206)
Recruiting
- Central Nervous System Neoplasms
- +22 more
-
Bethesda, MarylandNational Institutes of Health
Mar 1, 2022
Glioblastoma, Gliosarcoma Trial in Seattle (radiation, procedure, drug, biological, other)
Completed
- Glioblastoma
- Gliosarcoma
- 3-Dimensional Conformal Radiation Therapy
- +10 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Mar 4, 2022
Gliosarcoma, Recurrent Glioblastoma, Astrocytoma of Brain Trial in Palo Alto (Laboratory Biomarker Analysis, Pharmacological
Completed
- Gliosarcoma
- +3 more
- Laboratory Biomarker Analysis
- +2 more
-
Palo Alto, CaliforniaStanford University, School of Medicine
Aug 9, 2021
Anaplastic Astrocytoma, Anaplastic Ependymoma, Anaplastic Oligodendroglioma Trial in United States (other, drug, procedure)
Active, not recruiting
- Anaplastic Astrocytoma
- +6 more
- Laboratory Biomarker Analysis
- +4 more
-
Los Angeles, California
- +11 more
Jul 1, 2022
Brain Tumor, Astrocytoma, Astroglioma Trial run by the NCI (Zotiraciclib (TG02), Temozolomide (TMZ))
Completed
- Brain Tumor
- +4 more
- Zotiraciclib (TG02)
- Temozolomide (TMZ)
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Sep 3, 2021
Malignant Supratentorial Tumor, Recurrent Glioblastoma, Recurrent Gliosarcoma Trial in Houston (Lonafarnib, Temozolomide)
Active, not recruiting
- Malignant Supratentorial Neoplasm
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Dec 13, 2021
Recurrent Glioblastoma, Recurrent Gliosarcoma, Recurrent Supratentorial Glioblastoma Trial in Los Angeles (drug, radiation,
Withdrawn
- Recurrent Glioblastoma
- +3 more
- Akt/ERK Inhibitor ONC201
- +2 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
May 10, 2021
Adult Anaplastic Astrocytoma, Adult Anaplastic Ependymoma, Adult Anaplastic Oligodendroglioma Trial in Rochester (procedure,
Active, not recruiting
- Adult Anaplastic Astrocytoma
- +15 more
- biopsy
- +7 more
-
Rochester, MinnesotaMayo Clinic
Apr 8, 2022
Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma, Adult Giant Cell Glioblastoma Trial in Duarte (biological,
Completed
- Adult Anaplastic Astrocytoma
- +6 more
- E. coli CD-expressing genetically modified neural stem cells
- +4 more
-
Duarte, CaliforniaCity of Hope Medical Center
Sep 28, 2021
Brain Cancer, Brain Tumor, Glioma Trial in Canada, United States (DNX-2401, pembrolizumab)
Completed
- Brain Cancer
- +10 more
- DNX-2401
- pembrolizumab
-
Little Rock, Arkansas
- +14 more
Jul 13, 2021
Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma, Adult Diffuse Astrocytoma Trial in New York (other, drug,
Completed
- Adult Anaplastic Astrocytoma
- +8 more
- Laboratory Biomarker Analysis
- +3 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jun 28, 2021
Glial Cell Tumors, Malignant Gliomas, Glioblastoma Multiforme Trial in United States (Valproic acid, Bevacizumab, Radiation
Completed
- Glial Cell Tumors
- +7 more
- Valproic acid
- +2 more
-
Oklahoma City, Oklahoma
- +5 more
Jun 30, 2021
Glioblastoma, Gliosarcoma, Supratentorial Glioblastoma Trial in Houston (Mefloquine, Memantine Hydrochloride, Metformin
Active, not recruiting
- Glioblastoma
- +2 more
- Mefloquine
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Jun 16, 2021
Malignant Glioma, Grade 4 Malignant Glioma, Glioblastoma Trial in Durham (Radiation Therapy, Temozolomide, Bevacizumab)
Completed
- Malignant Glioma
- +3 more
- Radiation Therapy
- +2 more
-
Durham, North CarolinaDuke Cancer Center
Jan 6, 2021
Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma Trial in United States (bevacizumab, radiation therapy)
Completed
- Adult Giant Cell Glioblastoma
- +3 more
- bevacizumab
- radiation therapy
-
Birmingham, Alabama
- +30 more
Dec 27, 2022
Glioblastoma, Glioma, Gliosarcoma Trial in United States (Bevacizumab, TTFields Therapy)
Terminated
- Glioblastoma
- +2 more
- Bevacizumab
- TTFields Therapy
-
La Jolla, California
- +10 more
May 12, 2021
Glioblastoma, Glioblastoma Multiforme, Gliosarcoma Trial in San Francisco (enzastaurin, temozolomide, radiation therapy)
Completed
- Glioblastoma
- +2 more
- enzastaurin
- +2 more
-
San Francisco, CaliforniaFor additional information regarding investigative sites for thi
Jul 23, 2020
Pilomyxoid Astrocytoma, Pilocytic Astrocytoma, Glioma, Astrocytic Trial in New Hyde Park (Mebendazole, Vincristine, Carboplatin)
Recruiting
- Pilomyxoid Astrocytoma
- +11 more
- Mebendazole
- +5 more
-
New Hyde Park, New YorkCohen Children's Medical Center of New York
Mar 3, 2021